NASDAQ:HLNE - Nasdaq - US4074971064 - Common Stock - Currency: USD
HLNE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 230 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making HLNE a very profitable company, without any liquidiy or solvency issues. HLNE shows excellent growth, but is valued quite expensive already. This makes HLNE very considerable for growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.53% | ||
ROE | 33.16% | ||
ROIC | 20.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 45.75% | ||
PM (TTM) | 31.13% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | 1.07 | ||
Altman-Z | 8.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.24 | ||
Quick Ratio | 1.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.82 | ||
Fwd PE | 32.82 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 42.15 | ||
EV/EBITDA | 34.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.32% |
160.59
+4.97 (+3.19%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.32% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.82 | ||
Fwd PE | 32.82 | ||
P/S | 16.63 | ||
P/FCF | 42.15 | ||
P/OCF | 40.61 | ||
P/B | 17.72 | ||
P/tB | 17.72 | ||
EV/EBITDA | 34.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.53% | ||
ROE | 33.16% | ||
ROCE | 26.45% | ||
ROIC | 20.87% | ||
ROICexc | 28.54% | ||
ROICexgc | 29.5% | ||
OM | 45.75% | ||
PM (TTM) | 31.13% | ||
GM | N/A | ||
FCFM | 39.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | 1.07 | ||
Debt/EBITDA | 0.9 | ||
Cap/Depr | 108.93% | ||
Cap/Sales | 1.49% | ||
Interest Coverage | 250 | ||
Cash Conversion | 86.92% | ||
Profit Quality | 126.78% | ||
Current Ratio | 1.24 | ||
Quick Ratio | 1.24 | ||
Altman-Z | 8.64 |